The frontiers of genetic medicine - from biohacking to the clinic

​Speaker Spotlight: Matt Scholtz

​Founder and Chief Executive Officer at Oisín Biotechnologies

​Join us for an insightful session with Matthew Scholz, a visionary serial entrepreneur at the intersection of biotech and innovation. With a background in computer security, immunology, and gene therapy, Matt is the Founder and CEO of Oisín Biotechnologies, a company pioneering gene-targeted therapies to eliminate unwanted cells.

​He also leads OncoSenX, an oncology-focused spin-out of Oisín, driving new frontiers in cancer treatment.

​Previously, Matt founded Immusoft in 2009, where he served as CEO until 2017. He remains an active board member, supporting the company’s mission to program patients’ B cells to produce therapeutic proteins.

​This session promises a fascinating look at the future of longevity and cell-based therapies from one of the field’s most inventive minds.